Prashanth Venkatesh
Adult Congenital Heart Disease · Los Angeles, CANPI 1629496781
Payments from drug & device makers
What this record shows
Medtronic accounts for 71.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $2,313 and has fallen 98.7% since, to $31 in 2025.
Across 31 payments — averaging $95.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abbott$357
- Actelion Pharmaceuticals US, Inc.$142
- Esperion Therapeutics, Inc.$104
- Pfizer$96
- Heartflow, Inc.$40
- plus $93 from 3 others
What the payments were for
- Travel & lodging$1,44349%
- Food & beverage$1,50551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 21 | $2,116 |
| Abbott | 3 | $357 |
| Actelion Pharmaceuticals US, Inc. | 1 | $142 |
| Esperion Therapeutics, Inc. | 1 | $104 |
| Pfizer | 1 | $96 |
| Heartflow, Inc. | 1 | $40 |
| Lantheus Medical Imaging, Inc. | 1 | $38 |
| GE HealthCare | 1 | $31 |
| Lilly USA, LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few adult congenital heart disease providers in Californiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult congenital heart disease in Los Angeles
- Priya PillutlaLos Angeles$4K
- David LaughrunLos Angeles$101
- Taylor HolveSanta Barbara$15K
- Angela LiOrange$8K
- Ahmed KheiwaLoma Linda$5K
- Ramesh BansalLoma Linda$2K
- Padmini VaradarajanRedlands$1K
- Karen SchultzSacramento$825
- Jeannette LinOrange$569
- Daniel ClarkStanford$311
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.